Collectively, these results establish PAK2 as a downstream mediator of Cd‐induced H3K79me1 modification that orchestrates autophagy blockade and facilitates malignant progression by increasing the proliferative, migratory, and invasive capacities of BC cells. Here, PAK2 is linked to breast cancer.